HFXE ETF Analysis

For informational purposes only. Not financial advice.

Quick Answer

With a dividend yield of 2.27% and a beta of 0.91, HFXE aims to provide a blend of income and moderate market participation. Investors should note the fund's concentrated nature and consider its suitability within a broader portfolio context. Past performance does not guarantee future results.

HFXE ETF — Price, Holdings & Analysis

HFXE European equities, primarily focusing on large-cap companies. The fund's top holdings include Nestle SA, Roche Holding AG, and Novartis AG, reflecting a tilt towards established multinational corporations. With a dividend yield of 2.27% and a beta of 0.91, HFXE aims to provide a blend of income and moderate market participation. Investors should note the fund's concentrated nature and consider its suitability within a broader portfolio context. Past performance does not guarantee future results.

ETF Overview

HFXE provides targeted exposure to a select group of European companies, distinguishing itself through its highly. This approach contrasts with more diversified European equity ETFs, which typically hold hundreds of stocks. The fund's strategy centers on investing in established, large-cap companies, as evidenced by its top holdings in Nestle SA (4.02%), Roche Holding AG (3.10%), and Novartis AG (2.37%). These companies represent a mix of consumer staples and healthcare, indicating a potential focus on stable, dividend-paying stocks. The inclusion of technology companies like ASML Holding NV (1.68%) and SAP SE (1.58%) suggests a blend of traditional and growth-oriented sectors. Investors seeking concentrated exposure to leading European brands may find HFXE appealing, but should be aware of the increased risk associated with a less diversified portfolio. Past performance does not guarantee future results.

Risk Metrics

HFXE's introduces a significant level of concentration risk. A downturn in any of its top holdings could have a disproportionately large impact on the fund's overall performance. The fund's sector allocation also contributes to its risk profile, with a notable emphasis on consumer staples and healthcare. While these sectors are generally considered defensive, they may underperform during periods of strong economic growth. With a beta of 0.91, HFXE exhibits slightly lower volatility compared to the broader market. However, the concentrated nature of the fund could amplify its price swings relative to more diversified benchmarks. Investors should carefully consider their risk tolerance and investment horizon before investing in HFXE. Past performance does not guarantee future results.

What does HFXE hold?

Holding	Weight
Nestle SA (NESN)	4.02%
Roche Holding AG Dividend Right Cert. (ROG)	3.10%
Novartis AG (NOVN)	2.37%
AstraZeneca PLC (AZN.L)	1.79%
ASML Holding NV (ASML)	1.68%
SAP SE (SAP.DE)	1.58%
Novo Nordisk A/S B (NOVO B)	1.39%
Sanofi SA (SAN.PA)	1.36%
LVMH Moet Hennessy Louis Vuitton SE (MC.PA)	1.34%
GlaxoSmithKline PLC (GSK.L)	1.30%

Dividend Yield

2.27%

Risk Metrics

Beta: 0.91

Questions & Answers

What is HFXE and what does it track?

HFXE is an exchange-traded fund (ETF) that provides concentrated exposure to a select group of European equities. Unlike broad-based European equity ETFs, focusing on large-cap, well-established businesses.

The fund's top holdings include names like Nestle SA, Roche Holding AG, and Novartis AG, reflecting a bias towards stable, dividend-paying stocks.

What are the top holdings in HFXE?

HFXE's top holdings reflect its concentrated investment strategy, with a significant portion of its assets allocated to a small number of companies.

As of 2026-03-15, the top three holdings in HFXE are Nestle SA (4.02%), Roche Holding AG (3.10%), and Novartis AG (2.37%).

Is HFXE a good long-term investment?

Whether HFXE is a suitable long-term investment depends on an individual investor's specific circumstances and risk tolerance. The fund's European equities offers the potential for higher returns, but also carries a greater degree of risk compared to more diversified strategies.

HFXE's dividend yield of 2.27% may appeal to income-seeking investors.

How does HFXE compare to similar ETFs?

HFXE distinguishes itself from similar European equity ETFs through its highly. Most European equity ETFs hold hundreds of stocks, providing broader diversification.

HFXE's concentrated approach may lead to higher returns if its selected companies outperform, but it also increases the risk of underperformance if those companies struggle.

Does HFXE pay dividends?

Yes, HFXE distributes dividends to its shareholders. As of 2026-03-15, HFXE has a dividend yield of 2.27%. This means that for every $100 invested in HFXE, investors can expect to receive approximately $2.27 in dividend income annually.

The dividend yield can fluctuate over time depending on the fund's underlying holdings and market conditions.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Data provided for informational purposes only.

Written by machine, not reviewed page by page. Editorial oversight is systemic: the rules and the sources are checked, individual pages are not.